MAM
MRNA icon

Martingale Asset Management’s Moderna MRNA Stock Holding History

Martingale Asset Management’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-12,228
Closed -$1.28M – 883
2020
Q4 		$1.28M Sell
12,228
-2,995
-20% -$303K 0.01% 386
2020
Q3 		$1.08M Buy
15,223
+2,906
+24% +$203K 0.01% 610
2020
Q2 		$791K Buy
+12,317
New +$675K 0.01% 786

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return

Martingale Asset Management's MRNA Position: Q1 2021 in Review

Martingale Asset Management sold out of Moderna (MRNA) in Q1 2021, closing a stake of 12,228 shares — an estimated $1.28M sold.

Martingale Asset Management first reported a position in MRNA in Q2 2020 and held it in 3 quarters. The position peaked at $1.28M in Q4 2020. 776 funds tracked by Wall St. Rank hold MRNA as of Q1 2021.

  • Martingale Asset Management reported no remaining Moderna position as of Q1 2021 after selling out during the quarter.
  • Martingale Asset Management sold 12,228 Moderna shares in Q1 2021, an estimated $1.28M.
  • Martingale Asset Management first reported a position in Moderna in Q2 2020 and held it in 3 quarters.
  • Martingale Asset Management's Moderna position peaked at $1.28M in Q4 2020.
  • 776 funds tracked by Wall St. Rank held Moderna as of Q1 2021.

Based on Martingale Asset Management's 13F filing for Q1 2021, filed 13 May 2021.